Aptevo Therapeutics competitorsClear all

Aptevo Therapeutics's top competitors include Ourotech, Harpoon Therapeutics, Aeglea Biotherapeutics and Heat Biologics.
Aptevo Therapeutics
Aptevo Therapeutics
Aptevo Therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market.
Ourotech
Ourotech
Ourotech is changing the way cancer drugs are tested for the most innovative treatments.
Harpoon Therapeutics
Harpoon Therapeutics
Harpoon Therapeutics is a preclinical stage biotechnology company.
Aeglea Biotherapeutics
Aeglea Biotherapeutics
Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.
Heat Biologics
Heat Biologics
Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.
Founding Date
Founding Date
2016
Founding Date
2015
Founding Date
2015
Founding Date
2013
Founding Date
2008
Type
Type
Public
Type
Private
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Seattle, US HQ
Locations
Waterloo, CA HQ
Locations
South San Francisco, US HQ
South San Francisco, US
Locations
Austin, US HQ
Austin, US
Locations
Durham, US HQ
Morrisville, US
Employees
Employees
1182% decrease
Employees
3
Employees
45
Employees
761% increase
Employees
3058% increase
Valuation ($)
Valuation ($)
190.6 m
Valuation ($)
N/A
Valuation ($)
339.8 m
Valuation ($)
394.5 m
Valuation ($)
175.8 m
Alexa Website Rank
Alexa Website Rank
358229
Alexa Website Rank
N/A
Alexa Website Rank
252051
Alexa Website Rank
401753
Alexa Website Rank
245002
Employee Rating
Employee Rating
4.3
Employee Rating
N/A
Employee Rating
5
Employee Rating
4.3
Employee Rating
N/A

Financial

Revenue (est.)
Revenue (est.)
$32.4m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$5.8m (FY, 2019)
Revenue (est.)
N/A
Revenue (est.)
$3m (FY, 2019)
Net income
Net income
($40.4m) (FY, 2019)
Net income
N/A
Net income
($55.6m) (FY, 2019)
Net income
($78.3m) (FY, 2019)
Net income
($20.4m) (FY, 2019)
For sources of this data, please see the company profile

View company profiles

Ourotech
HQ
Waterloo, CA
Employees
3

Ourotech is changing the way cancer drugs are tested for the most innovative treatments.

View company
Harpoon Therapeutics
HQ
South San Francisco, US
Employees
45

Harpoon Therapeutics is a preclinical stage biotechnology company.

View company
Aeglea Biotherapeutics
HQ
Austin, US
Employees
76↑ 1% increase

Aeglea BioTherapeutics is a biotechnology company committed to developing enzyme-based therapeutics in the field of amino acid metabolism to treat rare genetic diseases and cancer.

View company
Heat Biologics
HQ
Durham, US
Employees
30

Heat Biologics is a clinical-stage company focused on developing its proprietary “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) fully allogeneic “off-the-shelf” cell based immunotherapy to treat patients with a wide array of cancers and infectious diseases.

View company